Overdose and anaphylaxis are two serious medical emergencies that require immediate intervention and can be fatal if not treated in time. Supplying every AED first-aid box with epinephrine ...

Sens. Susan Collins (R-ME) and Claire McCaskill (D-MO) sent five identical letters late last week to opioid overdose antidote manufacturers Pfizer, Amphastar Pharmaceuticals, Mylan, Kaléo Pharma and ...

The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...

Kaléo rolled out two initiatives to increase access to its opioid overdose reversal drug Evzio, the company announced April 5. Here are four things to know. 1. Kaléo already covers out-of-pocket costs ...

Over the course of the past few weeks Mylan has replaced Turing and Valeant as the most scrutinized and critiqued pharmaceutical companies in the United States. Though politicians and pundits have ...

Richmond, Virginia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced it received the Prototype Innovation award ...

The US Food and Drug Administration (FDA) has announced new action to encourage companies to develop naloxone products for over-the-counter (OTC) use — or apply to switch certain products from ...

The case of the opioid overdose antidote naloxone (also known as Narcan) offers an interesting look at how states can offer a prescription drug without a prescription at local pharmacies, even though ...

An Arizona cancer doctor on why every home with opioid prescriptions should keep naloxone within reach and why most who have it will never use it.

The MarketWatch News Department was not involved in the creation of this content. Richmond, Virginia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and ...